Generic Injectables Global Market Report 2024

Description

“Generic Injectables Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on generic injectables market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for generic injectables? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The generic injectables market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Product Type: Monoclonal Antibodies; Cytokines; Insulin; Vaccines; Other Products
2) By Container Type: Vials; Ampoules; Premix; Prefilled Syringes; Other Containers
3) By Route Of Administration: Intravenous; Intramuscular; Subcutaneous; Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Drug Stores; Online Prescription Stores
5) By Application: Oncology; Diabetes ; Infectious Diseases ; Blood Disorders ; Musculoskeletal Disorders ; Hormonal Disorders ; Pain Management ; CNS Diseases ; Cardiovascular Diseases
Companies Mentioned: Baxter International Inc.; Sanofi SA; AstraZeneca plc.; Fresenius Medical Care AG & Co. KGaA; Johnson & Johnson
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Generic injectables, also known as sterile injectables, are medications identical in dosage, strength, performance, intended use, potential side effects, and method of administration to branded injectables. These drugs demonstrate bioequivalence, ensuring they function in the same way as their brand-name counterparts, delivering equivalent therapeutic benefits.

Within the realm of generic injectables, diverse categories exist, including monoclonal antibodies, cytokines, insulin, vaccines, and more. Monoclonal antibodies, for instance, are artificial proteins mirroring natural antibodies in the human body. They find application in treating various conditions such as breast cancer, leukemia, asthma, macular degeneration, arthritis, Crohn's disease, and transplant-related issues.

These injectables are packaged in various containers such as vials, ampoules, premix solutions, and prefilled syringes. Their administration involves different routes such as intravenous, intramuscular, subcutaneous, and others. These medications are distributed through channels including hospital pharmacies, retail pharmacies, drug stores, and online prescription outlets. They serve diverse medical conditions spanning oncology, diabetes, infectious diseases, blood disorders, musculoskeletal disorders, hormonal disorders, pain management, central nervous system (CNS) ailments, and cardiovascular diseases.

The generic injectables market research report is one of a series of new reports from The Business Research Company that provides generic injectables market statistics, including generic injectables industry global market size, regional shares, competitors with a generic injectables market share, detailed generic injectables market segments, market trends and opportunities, and any further data you may need to thrive in the generic injectables industry. This generic injectables market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The generic injectables market size has grown rapidly in recent years. It will grow from $109.42 billion in 2023 to $125.97 billion in 2024 at a compound annual growth rate (CAGR) of 15.1%. Historical growth in this sector can be attributed to several factors, including the pursuit of cost-effectiveness, patent expirations opening avenues for generic alternatives, initiatives aimed at improving healthcare access, intensified market competition, and evolving global pharmaceutical trends.

The generic injectables market size is expected to see rapid growth in the next few years. It will grow to $209.47 billion in 2028 at a compound annual growth rate (CAGR) of 13.6%. Anticipated growth in the forecast period is expected due to various factors, notably the expanding aging population, strategic alliances between industry players, regulatory shifts, heightened awareness about healthcare, and a surge in market innovation.

The anticipated increase in cancer and cardiovascular diseases is set to drive the growth of the generic injectable market. Cancer, characterized by uncontrolled cell growth, and cardiovascular diseases affecting the heart and blood vessels are prevalent health concerns. Generic injectables play a vital role in treating these conditions by offering pharmaceutical equivalence to brand-name drugs. In 2022, approximately 74% of the 41 million global deaths attributed to noncommunicable diseases (NCDs) were due to cardiovascular diseases (17.9 million deaths) and cancer (9.3 million deaths). The availability of these injectables enhances treatment accessibility and affordability, contributing to the market's growth.

The expanding population of elderly individuals is expected to fuel the growth of the generic injectables market. As populations age due to increased life expectancy and declining fertility rates, the demand for generic injectables rises. These pharmaceuticals are commonly used in managing health conditions prevalent among older individuals, such as diabetes, cardiovascular diseases, and osteoporosis. For instance, projections indicate that by 2041, Australia's population aged 65 and above will grow by 54% to 6.66 million from an estimated 4.31 million in 2021. This demographic shift drives the demand for generic injectables catering to the healthcare needs of aging populations.

Product innovation emerges as a prominent trend shaping the generic injectables market. Key players in this market focus on advancing generic injectables to maintain competitiveness. In April 2022, Dr. Reddy's Laboratories, an Indian pharmaceutical company, introduced Treprostinil Injection in the U.S. market. This injection, approved by the U.S. Food and Drug Administration (USFDA), serves as a therapeutic equivalent generic version of Remodulin (treprostinil) Injection. It facilitates a smooth transition for patients requiring a shift from epoprostenol, aiding in the reduction of clinical deterioration.

Major companies in the generic injectables market are forging strategic partnerships and collaborations to fortify their market position. These partnerships, aimed at achieving specific business objectives, play a pivotal role in sustaining market presence. For example, in December 2023, ITAAN Pharma, a Canadian pharmaceutical company specializing in injectable medications, collaborated with ACIC Pharmaceuticals, also based in Canada. This strategic alliance aims to jointly develop generic injectables targeting the North American market, leveraging the strengths of both entities for mutual growth and success.

In April 2022, Hikma Pharmaceuticals PLC, a US-based biopharmaceutical firm, completed the acquisition of Custopharm Inc for $425 million. This strategic move by Hikma is geared towards broadening its portfolio of injectable medications while bolstering its research and development capabilities. Custopharm, also based in the US, specializes in generic pharmaceutical products, notably in the realm of generic injectables, aligning well with Hikma's objectives for portfolio expansion and R&D advancement.

Major companies operating in the generic injectables market report are Baxter International Inc., Sanofi SA, AstraZeneca plc., Fresenius Medical Care AG & Co. KGaA, Johnson & Johnson, Merck & Co. Inc., Biocon Limited, Lupin Limited, Dr. Reddy's Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Cipla Limited, Aurobindo Pharma Limited, Samsung Biologics Co. Ltd., Piramal Pharma Limited, Amgen Inc., Bristol-Myers Squibb Company, Pfizer Inc., Hikma Pharmaceuticals PLC, Par Pharmaceutical, Pharmascience Inc., SAGENT Pharmaceuticals, AmerisourceBergen Corporation, Hospira Inc., Sandoz International GmbH, Singota Solutions Inc., MVASI Bevacizumab-awwb Syringes, Mylan N.V., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Endo International plc, Akorn Pharmaceuticals Inc., Wockhardt Limited

North America was the largest region in the generic injectable market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the generic injectables market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the generic injectables market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The generic injectables market consists of sales of drug solutions, dry solid injectables, drug solids suspended in a liquid medium, drug suspension for injection, drug emulsions, and biological injectables. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r11757

1. Executive Summary

2. Generic Injectables Market Characteristics

3. Generic Injectables Market Trends And Strategies

4. Generic Injectables Market - Macro Economic Scenario

4.1. Impact Of High Inflation On the Market
4.2. Ukraine-Russia War Impact On the Market
4.3. COVID-19 Impact On the Market

5. Global Generic Injectables Market Size and Growth

5.1. Global Generic Injectables Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Generic Injectables Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Generic Injectables Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Generic Injectables Market Segmentation

6.1. Global Generic Injectables Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Monoclonal Antibodies
Cytokines
Insulin
Vaccines
Other Products
6.2. Global Generic Injectables Market, Segmentation By Container Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Vials
Ampoules
Premix
Prefilled Syringes
Other Containers
6.3. Global Generic Injectables Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Intravenous
Intramuscular
Subcutaneous
Other Routes Of Administration
6.4. Global Generic Injectables Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Drug Stores
Online Prescription Stores
6.5. Global Generic Injectables Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Oncology
Diabetes
Infectious Diseases
Blood Disorders
Musculoskeletal Disorders
Hormonal Disorders
Pain Management
CNS Diseases
Cardiovascular Diseases

7. Generic Injectables Market Regional And Country Analysis

7.1. Global Generic Injectables Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Generic Injectables Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Generic Injectables Market

8.1. Asia-Pacific Generic Injectables Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Generic Injectables Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Generic Injectables Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Generic Injectables Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Generic Injectables Market

9.1. China Generic Injectables Market Overview
9.2. China Generic Injectables Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Generic Injectables Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Generic Injectables Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Generic Injectables Market

10.1. India Generic Injectables Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Generic Injectables Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Generic Injectables Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Generic Injectables Market

11.1. Japan Generic Injectables Market Overview
11.2. Japan Generic Injectables Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Generic Injectables Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Generic Injectables Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Generic Injectables Market

12.1. Australia Generic Injectables Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Generic Injectables Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Generic Injectables Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Generic Injectables Market

13.1. Indonesia Generic Injectables Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Generic Injectables Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Generic Injectables Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Generic Injectables Market

14.1. South Korea Generic Injectables Market Overview
14.2. South Korea Generic Injectables Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Generic Injectables Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Generic Injectables Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Generic Injectables Market

15.1. Western Europe Generic Injectables Market Overview
15.2. Western Europe Generic Injectables Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Generic Injectables Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Generic Injectables Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Generic Injectables Market

16.1. UK Generic Injectables Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Generic Injectables Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Generic Injectables Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Generic Injectables Market

17.1. Germany Generic Injectables Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Generic Injectables Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Generic Injectables Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Generic Injectables Market

18.1. France Generic Injectables Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Generic Injectables Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Generic Injectables Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Generic Injectables Market

19.1. Italy Generic Injectables Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Generic Injectables Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Generic Injectables Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Generic Injectables Market

20.1. Spain Generic Injectables Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Generic Injectables Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Generic Injectables Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Generic Injectables Market

21.1. Eastern Europe Generic Injectables Market Overview
21.2. Eastern Europe Generic Injectables Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Generic Injectables Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Generic Injectables Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Generic Injectables Market

22.1. Russia Generic Injectables Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Generic Injectables Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Generic Injectables Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Generic Injectables Market

23.1. North America Generic Injectables Market Overview
23.2. North America Generic Injectables Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Generic Injectables Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Generic Injectables Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Generic Injectables Market

24.1. USA Generic Injectables Market Overview
24.2. USA Generic Injectables Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Generic Injectables Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Generic Injectables Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Generic Injectables Market

25.1. Canada Generic Injectables Market Overview
25.2. Canada Generic Injectables Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Generic Injectables Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Generic Injectables Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Generic Injectables Market

26.1. South America Generic Injectables Market Overview
26.2. South America Generic Injectables Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Generic Injectables Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Generic Injectables Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Generic Injectables Market

27.1. Brazil Generic Injectables Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Generic Injectables Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Generic Injectables Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Generic Injectables Market

28.1. Middle East Generic Injectables Market Overview
28.2. Middle East Generic Injectables Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Generic Injectables Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Generic Injectables Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Generic Injectables Market

29.1. Africa Generic Injectables Market Overview
29.2. Africa Generic Injectables Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Generic Injectables Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Generic Injectables Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Generic Injectables Market Competitive Landscape And Company Profiles

30.1. Generic Injectables Market Competitive Landscape
30.2. Generic Injectables Market Company Profiles
- 30.2.1. Baxter International Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Sanofi SA
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. AstraZeneca plc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Fresenius Medical Care AG & Co. KGaA
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Johnson & Johnson
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Generic Injectables Market Competitive Benchmarking

32. Global Generic Injectables Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Generic Injectables Market

34. Generic Injectables Market Future Outlook and Potential Analysis

34.1 Generic Injectables Market In 2028 - Countries Offering Most New Opportunities
34.2 Generic Injectables Market In 2028 - Segments Offering Most New Opportunities
34.3 Generic Injectables Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer